Andrew Hykes - Feb 16, 2024 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Feb 16, 2024
Transactions value $
$2,611,859
Form type
4
Date filed
2/21/2024, 09:52 PM
Previous filing
Jan 3, 2024
Next filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Award $0 +40.8K +9.44% $0.00 473K Feb 16, 2024 Direct F1, F2
holding NARI Common Stock 1.55K Feb 16, 2024 By Child 1
holding NARI Common Stock 1.55K Feb 16, 2024 By Child 2
holding NARI Common Stock 1.55K Feb 16, 2024 By Child 3
holding NARI Common Stock 1K Feb 16, 2024 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to Buy) Award $2.61M +44.7K $58.44 44.7K Feb 16, 2024 Common Stock 44.7K $58.44 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents annual restricted stock units ("RSUs") awarded to the reporting person, with a vesting commencement date of January 1, 2024 (the "Vesting Commencement Date"). 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.
F2 Includes 156 shares acquired on January 31, 2024, under the Company's Employee Stock Purchase Plan.
F3 Represents options to purchase shares of Issuer common stock which were granted on February 16, 2024 under the Issuer's 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis, with the first tranche vesting on April 1, 2024.